Catalent launches big changes to the executive team

The US drug contractor takes dramatic steps after finding significant weaknesses in its cost management.
Photo: Catalent/pr
Photo: Catalent/pr
by ulrich quistgaard, translated by kristoffer grønbæk

Just ahead of the weekend, US-based drug contractor Catalent announced a string of measures to clean up its business after identifying problematic weaknesses in its cost management, industry media Endpoints reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading